XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-based Awards The following table summarizes the stock options activity under the 2010 Plan and 2019 Plan for the three months ended March 31, 2022:
Stock Options Outstanding
(in thousands, except year and per share data)
Shares Subject to Options OutstandingWeighted- Average Exercise Price per OptionWeighted- Average Remaining Contractual Terms (in years)Aggregate Intrinsic Value
Balances as of December 31, 202113,603 $12.47 6.0$1,726,440 
Options granted — $— 
Options exercised (857)$3.49 $87,101 
Options canceled/forfeited/expired (3)$2.77 
Balances as of March 31, 202212,743 $15.13 5.75$1,437,112 
Vested and expected to vest as of March 31, 202212,739 $4.91 5.75$1,436,612 
Exercisable as of March 31, 202211,793 $2.62 5.56$1,380,741 
Schedule of Restricted Stock Units Activity
RSU and restricted stock activity for the three months ended March 31, 2022 was as follows:
Restricted Stock and RSUsWeighted-Average
Grant
Date Fair Value
(in thousands, except per share data)
Unvested and outstanding as of December 31, 20217,456 $47.36 
Granted - RSUs863 $102.25 
Granted - Restricted stock52 $100.29 
Vested - RSUs(709)$31.63 
Vested - Restricted stock(655)$100.29 
Forfeited (173)$48.17 
Unvested as of March 31, 20226,834 $55.45 
Vested and not yet released— $— 
Outstanding as of March 31, 20226,834 $55.45 
Schedule of Fair Value Assumptions for Employee Stock Purchase Plan The weighted-average assumptions used to determine the fair value of the ESPP during the periods presented were as follows:
Three Months ended March 31,
20222021
Expected term (in years)0.50.5
Risk-free interest rate0.1 %0.1 %
Expected volatility44.0 %59.7 %
Dividend yield— %— %
Schedule of Stock-based Compensation Expense
The following table sets forth the total stock-based compensation expense included in the Company’s condensed consolidated statements of operations:
Three Months Ended March 31,
20222021
(in thousands)
Cost of revenue$1,078 $414 
Sales and marketing8,919 5,645 
Research and development18,829 8,364 
General and administrative5,139 3,615 
Total stock-based compensation expense$33,965 $18,038